BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 12509463)

  • 1. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
    Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
    Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.
    Wu L; Sun T; Kobayashi K; Gao P; Griffin JD
    Mol Cell Biol; 2002 Nov; 22(21):7688-700. PubMed ID: 12370315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway.
    Krebs LT; Deftos ML; Bevan MJ; Gridley T
    Dev Biol; 2001 Oct; 238(1):110-9. PubMed ID: 11783997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling.
    Berezovska O; Jack C; McLean P; Aster JC; Hicks C; Xia W; Wolfe MS; Kimberly WT; Weinmaster G; Selkoe DJ; Hyman BT
    J Neurochem; 2000 Aug; 75(2):583-93. PubMed ID: 10899933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function.
    Das I; Craig C; Funahashi Y; Jung KM; Kim TW; Byers R; Weng AP; Kutok JL; Aster JC; Kitajewski J
    J Biol Chem; 2004 Jul; 279(29):30771-80. PubMed ID: 15123653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of presenilin-independent Notch signaling.
    Berechid BE; Kitzmann M; Foltz DR; Roach AH; Seiffert D; Thompson LA; Olson RE; Bernstein A; Donoviel DB; Nye JS
    J Biol Chem; 2002 Mar; 277(10):8154-65. PubMed ID: 11756438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex.
    Fryer CJ; Lamar E; Turbachova I; Kintner C; Jones KA
    Genes Dev; 2002 Jun; 16(11):1397-411. PubMed ID: 12050117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 acts as a transcriptional coactivator for mammalian Notch-1.
    Oswald F; Täuber B; Dobner T; Bourteele S; Kostezka U; Adler G; Liptay S; Schmid RM
    Mol Cell Biol; 2001 Nov; 21(22):7761-74. PubMed ID: 11604511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for presenilin 1 in facilitating lagged 2-mediated endoproteolysis and signaling of notch 1.
    Martys-Zage JL; Kim SH; Berechid B; Bingham SJ; Chu S; Sklar J; Nye J; Sisodia SS
    J Mol Neurosci; 2000 Dec; 15(3):189-204. PubMed ID: 11303783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of activator protein-1-mediated transcriptional activation by the Notch-1 intracellular domain.
    Chu J; Jeffries S; Norton JE; Capobianco AJ; Bresnick EH
    J Biol Chem; 2002 Mar; 277(9):7587-97. PubMed ID: 11739397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex.
    Nam Y; Weng AP; Aster JC; Blacklow SC
    J Biol Chem; 2003 Jun; 278(23):21232-9. PubMed ID: 12644465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene.
    Wu L; Kobayashi K; Sun T; Gao P; Liu J; Nakamura M; Weisberg E; Mukhopadhyay NK; Griffin JD
    Gene; 2004 Mar; 328():153-65. PubMed ID: 15019995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation.
    Miyamoto A; Lau R; Hein PW; Shipley JM; Weinmaster G
    J Biol Chem; 2006 Apr; 281(15):10089-97. PubMed ID: 16492672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human protein with sequence similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters.
    Kitagawa M; Oyama T; Kawashima T; Yedvobnick B; Kumar A; Matsuno K; Harigaya K
    Mol Cell Biol; 2001 Jul; 21(13):4337-46. PubMed ID: 11390662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line.
    Jeffries S; Robbins DJ; Capobianco AJ
    Mol Cell Biol; 2002 Jun; 22(11):3927-41. PubMed ID: 11997524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that C promoter-binding factor 1 binding is required for Notch-1-mediated repression of activator protein-1.
    Chu J; Bresnick EH
    J Biol Chem; 2004 Mar; 279(13):12337-45. PubMed ID: 14645224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression.
    Lleó A; Berezovska O; Ramdya P; Fukumoto H; Raju S; Shah T; Hyman BT
    J Biol Chem; 2003 Nov; 278(48):47370-5. PubMed ID: 12960155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between fibroblast growth factors and Notch regulate neuronal differentiation.
    Faux CH; Turnley AM; Epa R; Cappai R; Bartlett PF
    J Neurosci; 2001 Aug; 21(15):5587-96. PubMed ID: 11466430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.